信邦制药：补缴税款及滞纳金5078.69万元

Core Viewpoint - The company, Xinbang Pharmaceutical, announced a tax payment and late fee totaling 50.7869 million yuan, with the company itself responsible for 2.6957 million yuan and its subsidiaries for 48.0912 million yuan [1] Group 1 - The tax payment does not involve any administrative penalties and does not constitute prior accounting errors [1] - The related amounts will be included in the profit and loss for the year 2025, affecting the net profit attributable to the parent company, with specifics to be determined based on the annual audit results [1]